Vidac will use the new funds to initiate a Phase IIb trial of its lead candidate VDA-1102 in patients with actinic keratosis.

Complete response (CR) observed in 86% (12/14) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who ...

Dr Arshad Khanani shares insights, including data on anti-VEGF treatment and macular atrophy, fibrosis biomarkers, and PCV combination therapies.

Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in ...

Dr Colin Hopper, Associate Clinical Professor at University College London, President of the International Photodynamic Association, and world-leading expert on photodynamic therapy (also known as ...

Technology Networks asked a selection of startups featured in the ELRIG Drug Discovery 2024 Breakthrough Zone how their ...

The topline results showed that Amelus and BF-RhodoLED lamp therapy met primary and secondary endpoints in the Phase III ...

LAKELAND, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Metrc, the most trusted and experienced provider of cannabis regulatory technology systems in the U.S., announced a new contract with the Commonwealth ...

Dome-shaped macula does not affect visual outcomes in patients with high myopia who are treated with intravitreal ranibizumab.

Invion Therapeutics is deploying little known - but age old - photodynamic therapies to tackle a range of solid tumours ...

Self-assembling nanoscale drug particles combining photothermal and photodynamic effects offer potential for treating large ...